Basilea Pharmaceutica (BPMUF) Financial Statements

0 Followers

Basilea Pharmaceutica Financial Overview

Basilea Pharmaceutica's market cap is currently CHF1.06B. The company's EPS TTM is CHF4.26; its P/E ratio is 16.71; and it has a dividend yield of 4.02%. Basilea Pharmaceutica is estimated to report earnings on February 16, 2027, and the estimated EPS forecast is CHF5.13. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	CHF 232.40M	CHF 208.54M	CHF 157.63M	CHF 147.76M	CHF 148.12M
Gross Profit	CHF 193.10M	CHF 169.86M	CHF 130.84M	CHF 120.96M	CHF 124.05M
Operating Income	CHF 51.60M	CHF 61.18M	CHF 19.20M	CHF 18.54M	CHF 1.19M
EBITDA	CHF 53.41M	CHF 63.43M	CHF 25.14M	CHF 26.21M	CHF 6.72M
Net Income	CHF 40.20M	CHF 77.59M	CHF 10.45M	CHF 12.15M	CHF -6.83M
Balance Sheet
Cash & Short-Term Investments	CHF 162.34M	CHF 120.71M	CHF 59.90M	CHF 84.70M	CHF 148.70M
Total Assets	CHF 282.00M	CHF 257.76M	CHF 173.29M	CHF 220.85M	CHF 247.27M
Total Debt	CHF 89.22M	CHF 111.67M	CHF 128.61M	CHF 187.14M	CHF 218.96M
Net Debt	CHF 59.58M	CHF -9.03M	CHF 68.71M	CHF 150.57M	CHF 164.00M
Total Liabilities	CHF 154.06M	CHF 176.76M	CHF 183.29M	CHF 241.56M	CHF 305.87M
Stockholders' Equity	CHF 127.94M	CHF 81.00M	CHF -10.00M	CHF -20.71M	CHF -58.61M
Cash Flow
Free Cash Flow	CHF 59.23M	CHF 72.65M	CHF 13.21M	CHF 3.75M	CHF -32.88M
Operating Cash Flow	CHF 62.09M	CHF 74.36M	CHF 14.24M	CHF 7.06M	CHF -32.02M
Investing Cash Flow	CHF -2.86M	CHF -1.01M	CHF -1.03M	CHF 91.65M	CHF 3.58M
Financing Cash Flow	CHF -21.43M	CHF -13.16M	CHF -57.30M	CHF -45.25M	CHF 16.64M

Currency in CHF

Basilea Pharmaceutica Earnings and Revenue History

Income Statement >

Basilea Pharmaceutica Liabilities to Assets

Balance Sheet >

Basilea Pharmaceutica Cash Flow

Cash Flow >

Basilea Pharmaceutica Forecast EPS vs Actual EPS

Earnings >

Basilea Pharmaceutica financials statements